Health insurers and pharmacy benefit managers are not making the grade when it comes to access to medications for autoimmune diseases, according to a new study. But insurers say the study doesn't paint the full picture.
Health insurers and pharmacy benefit managers are not making the grade when it comes to access to medications for autoimmune diseases, according to a new study. But insurers say the study doesn't paint the full picture.